The APA 60th Institute on Psychiatric Services recently ended in Chicago, and the results of many research projects were presented there for the first time. ADHD is so common, has such wide ranging affects on patients lives, and the treatment have been very effective so far, so naturally there were a number of projects on treatment of this disorder. Medications for ADHD have been around for half a century, and one of the newest medications, lisdexamfetamine dimesylate (Vyvanese) was the focus...

